If you've been hearing about Ozempic, Wegovy, or Mounjaro lately, you've probably seen the term GLP-1 thrown around everywhere. Social media, your doctor's office, maybe even at dinner. So what is GLP-1, and why does it suddenly matter so much for weight loss?

It Starts in Your Gut

GLP-1 stands for glucagon-like peptide-1. Your body makes it naturally—mostly in your intestines—after you eat. It's one of several hormones that help regulate blood sugar and appetite. Researchers figured out decades ago that people with type 2 diabetes often had lower levels of this hormone, and that boosting it could improve glucose control.

What they didn't expect at first was how strongly it affected hunger. Give someone a GLP-1 agonist (a drug that mimics or amplifies the hormone), and they tend to eat less. Not because of willpower. Because the signal that says "I'm full" actually gets through.

How GLP-1 Agonists Work

A GLP-1 agonist isn't GLP-1 itself—it's a molecule engineered to behave like it. It binds to the same receptors in your brain and gut, so your body thinks there's more of the hormone present than there really is. The result: slower stomach emptying, reduced appetite, and in many people, steady weight loss over months.

The drugs also help your pancreas release insulin when blood sugar rises and reduce the amount of glucose your liver pumps out. That's why Ozempic and Mounjaro were originally approved for diabetes—and why they're still used for that. The weight loss was a welcome side effect that eventually led to separate FDA approvals for obesity.

The Main GLP-1 Meds You'll Hear About

Semaglutide (Ozempic for diabetes, Wegovy for weight loss) and tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) are the big two right now. Tirzepatide actually combines a GLP-1 agonist with a GIP agonist—another gut hormone—which seems to give it a slight edge for weight loss in studies. Both are injectables you take once a week.

There's also oral semaglutide (Rybelsus) for diabetes. It's a daily pill. The dosing and absorption are trickier, so it hasn't been approved for weight loss yet in the same way Wegovy has.

Why Dosing Matters

These drugs build up in your system. They have half-lives of about 5–7 days, depending on the molecule, which means each weekly dose adds to what's still in your body from last week. That accumulation is why doctors start low and ramp up slowly—and why it can take a few months to see where you'll end up.

If you're curious how that buildup works over time, our Ozempic dosage calculator simulates drug accumulation and weight loss projection based on your start date, weight, and current dose. It's not a substitute for your doctor's guidance, but it can help you visualize the timeline.

What to Expect

Most people lose 5–15% of their body weight over the first year, though results vary. Nausea, constipation, and sometimes heartburn are common side effects, especially early on. They often fade as you get used to the medication or as your dose stabilizes.

The bigger question for a lot of people: what happens when you stop? Studies show that many—not all—people regain weight after going off the drug. That's led some researchers to argue that GLP-1 agonists are better thought of as long-term tools, not short-term fixes. Your doctor can help you figure out what makes sense for your situation.

The Bottom Line

GLP-1 is a hormone your body uses to manage appetite and blood sugar. GLP-1 agonists are drugs that enhance that signal. They've become the most talked-about weight loss medications in decades because they work—for many people, they really do reduce hunger and help drop pounds. But they're not magic. They're prescription treatments with real side effects and real costs. If you're considering one, the best next step is a conversation with a doctor who knows your history.